Pharmacologic Substance
linagliptin
Brand Names:
Glyxambi; Jentadueto; Tradjenta; Trijardy
Effect:
Decreased Glucagon Secretion; Increased Insulin Secretion
May Treat:
Diabetes Mellitus, Type 2
More Information:
ChemID; DrugBank; DailyMed; PDR
Definitions related to linagliptin:
  • A potent, orally bioavailable dihydropurinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. The inhibition of DPP-4 by linagliptin appears to be longer lasting than that by some other DPP-4 inhibitors tested.
    NCI
    U.S. National Cancer Institute, 2021
  • A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS.
    NLM Medical Subject Headings
    U.S. National Library of Medicine, 2025
Try this search on: Farlex, Merriam-Webster, Oxford Dictionary, or Wordnik

This content should not be used in place of medically-reviewed decision support reference material or professional medical advice. Some terms may have alternate or updated definitions not reflected in this set. The definitions on this page should not be considered complete or up to date.